Siemens Healthineers (ETR:SHL)‘s stock had its “buy” rating reaffirmed by investment analysts at DZ Bank in a research note issued to investors on Friday, Borsen Zeitung reports.
Other analysts also recently issued research reports about the stock. JPMorgan Chase & Co. set a €34.00 ($39.53) price objective on shares of Siemens Healthineers and gave the company a “neutral” rating in a report on Wednesday, April 24th. Berenberg Bank set a €42.00 ($48.84) price objective on shares of Siemens Healthineers and gave the company a “buy” rating in a report on Thursday. Royal Bank of Canada set a €36.00 ($41.86) price objective on shares of Siemens Healthineers and gave the company a “neutral” rating in a report on Thursday. Goldman Sachs Group set a €34.50 ($40.12) price target on shares of Siemens Healthineers and gave the stock a “neutral” rating in a report on Thursday. Finally, UBS Group set a €36.00 ($41.86) price target on shares of Siemens Healthineers and gave the stock a “neutral” rating in a report on Thursday. Thirteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Siemens Healthineers has a consensus rating of “Hold” and an average price target of €37.91 ($44.08).
SHL stock opened at €37.62 ($43.74) on Friday. The stock has a market capitalization of $37.60 billion and a price-to-earnings ratio of 29.16. The company has a debt-to-equity ratio of 46.72, a current ratio of 1.44 and a quick ratio of 0.97. Siemens Healthineers has a 12 month low of €31.90 ($37.09) and a 12 month high of €39.95 ($46.45).
Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.
Featured Story: Leveraged Buyout (LBO)
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.